Franklin Genomic Advancements ETF (HELX)

• Market cap: $11M
• 1 day: 0.51%
• 5 days: -0.40%
• 1 month: 4.77%
• 3 months: -4.42%
• 6 months: -9.65%
• Year to date: -5.44%
• 1 year: -13.30%
• 5 years: -7.98%
• 10 years: 14.52%

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more funds holding

Funds holding: 8 [Q4 2024] → 8 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

2.48% less ownership

Funds ownership: 22.9% [Q4 2024] → 20.42% (-2.48%) [Q1 2025]

26% less capital invested

Capital invested by funds: $2.97M [Q4 2024] → $2.21M (-$767K) [Q1 2025]